is a Vienna-based MedTech company.
We develop, produce, and distribute tests, instruments and software for in-vitro diagnostics and research applications.
ALEX was the first ELISA based in vitro multiplex allergy test allowing simultaneous measurement of total IgE (tlgE) and specific IgE (slgE) against a plethora of allergen extracts and molecular allergens.
Continuing this tradition is its successor product ALEX2.
For laboratories with a lower through-put and little lab space, ImageXplorer is a suitable choice. This cost-effective system has a very low footprint (approx. 0.5 m², without PC/Laptop). The maximum number of samples per run is 96 MADx tests per working day.
ImageXplorer comes along with a lab rocker, 2 array holders and an incubation chamber.
Summer is calling - pollen-associated food allergy awaits many of us.
Molecular diagnosis is essential for the management and risk assessment of patients struggling with fruit allergy or pollen-related fruit allergy. The most important clinical task regarding fruit allergies is to identify the allergenic molecules and to screen out patients who are at high risk for systemic reactions.
Correct diagnosis of fruit allergies is not always easy and can be challenging. In fact, cross-reactive proteins can complicate the diagnosis of fruit allergy, as they can cause clinically irrelevant positive tests for cross-reactive foods. Therefore, molecular tests that include both cross-reactive components and primary food allergens are an important tool for precise diagnosis as well as dietary recommendations.
Much desired - and yet feared: the early summer .... means an unpleasant grass pollen allergy for every 5th among us6/2/2021 TopNews, Alex, TrendsAndTopics, Services
Most of us enjoy the first shafts of sunshine and the blooming meadows, however for every 5th among us this means - watery eyes, sneezing and runny noses. 20% of the population suffers from grass pollen allergy.
ALEX2® - the smart way of detecting house dust mite sensitisation.
Tens of thousands of tests can now be produced per month.
MADx founder and CEO Christian Harwanegg, as well as our co-founder Sascha Dennstedt are awared with the entrepreneur of the year award
MADx was the only Austrian life sciences company to convince the top-class selection jury in the Horizon 2020 funding program "EIC SME Instrument - Phase 2".